Clinical Trial Update: Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing prophylactic nepafenac and ketorolac versus placebo in patients undergoing cataract surgery to prevent macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)
• Nepafenac (nepafenac)

Snippet

Sponsor: Queen's University | Conditions: Macular Edema | Phase 4 | Status: COMPLETED